Gabriel Marc

Mr. Gabriel Marc

Faculty of Pharmacy, “Iuliu Hațieganu” University of Medicine and Pharmacy
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 April 2023 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
Alexandru SandorAlexandru Sandor
Alexandru Sandor
Ioana IonuțIoana Ionuț
Ioana Ionuț
GMGabriel Marc
Gabriel Marc
IOIlioara Oniga
Ilioara Oniga
DEDan Tudor Eniu
Dan Tudor Eniu
OOOvidiu Oniga
Ovidiu Oniga
The epidermal growth factor receptor (EGFR) plays a critical role in the tumorigenesis of various forms of cancer. Targeting the mutant forms of EGFR has been identified as an attractive therapeutic approach and led to the approval of three generations of inhibitors. The quinazoline core has emerged as a favorable scaffold for the development of novel EGFR inhibitors due to increased affinity for the active site of EGFR kinase. Currently, there are five first-generation (gefitinib, erlotinib, lapatinib, vandetanib, and icotinib) and two second-generation (afatinib and dacomitinib) quinazoline-based EGFR inhibitors approved for the treatment of various types of cancers. The aim of this review is to outline the structural modulations favorable for the inhibitory activity toward both common mutant (del19 and L858R) and resistance-conferring mutant (T790M and C797S) EGFR forms, and provide an overview of the newly synthesized quinazoline derivatives as potentially competitive, covalent or allosteric inhibitors of EGFR.

30 May 2019 in Molecules
Verified
Journal Article
Open access
PDF file
GMGabriel Marc
Gabriel Marc
ASAnca Stana
Anca Stana
Smaranda Dafina OnigaSmaranda Dafina Oniga
Smaranda Dafina Oniga
APAdrian Pirnau
Adrian Pirnau
Laurian VlaseLaurian Vlase
Laurian Vlase
OOOvidiu Oniga
Ovidiu Oniga
Oxidative stress has been incriminated in the physiopathology of many diseases, such as diabetes, cancer, atherosclerosis, and cardiovascular and neurodegenerative diseases. There is a great interest in developing new antioxidants that could be useful for preventing and treating conditions for which oxidative stress is suggested as the root cause. The thiazolidine-2,4-dione derivatives have been reported to possess various pharmacological activities and the phenol moiety is known as a pharmacophore in many naturally occurring and synthetic antioxidants. Twelve new phenolic derivatives of thiazolidine-2,4-dione were synthesized and physicochemically characterized. The antioxidant capacity of the synthesized compounds was assessed through several in vitro antiradical, electron transfer, and Fe2+ chelation assays. The top polyphenolic compounds 5f and 5l acted as potent antiradical and electron donors, with activity comparable to the reference antioxidants used. The ferrous ion chelation capacity of the newly synthesized compounds was modest. Several quantum descriptors were calculated in order to evaluate their influence on the antioxidant and antiradical properties of the compounds and the chemoselectivity of the radical generation reactions has been evaluated. The correlation with the energetic level of the frontier orbitals partially explained the antioxidant activity, whereas a better correlation was found while evaluating the O–H bond dissociation energy of the phenolic groups.

21 September 2018 in Molecules
Verified
Journal Article
Open access
PDF file
AAAnamaria Apan
Anamaria Apan
DLDenisa Leonte
Denisa Leonte
Laurian VlaseLaurian Vlase
Laurian Vlase
LBLaszlo Csaba Bencze
Laszlo Csaba Bencze
SISilvia Imre
Silvia Imre
VZValentin Zaharia
Valentin Zaharia
Non-steroidal anti-inflammatory drugs (NSAIDs) are an important pharmacological class of drugs used for the treatment of inflammatory diseases. They are also characterized by severe side effects, such as gastrointestinal damage, increased cardiovascular risk and renal function abnormalities. In order to synthesize new anti-inflammatory and analgesic compounds with a safer profile of side effects, a series of 2,6-diaryl-imidazo[2,1-b][1,3,4]thiadiazole derivatives 5a–l were synthesized and evaluated in vivo for their anti-inflammatory and analgesic activities in carrageenan-induced rat paw edema. Among all compounds, 5c showed better anti-inflammatory activity compared to diclofenac, the standard drug, and compounds 5g, 5i, 5j presented a comparable antinociceptive activity to diclofenac. None of the compounds showed ulcerogenic activity. Molecular docking studies were carried out to investigate the theoretical bond interactions between the compounds and target, the cyclooxygenases (COX-1/COX-2). The compound 5c exhibited a higher inhibition of COX-2 compared to diclofenac.

21 September 2019 in Molecules
Verified
Journal Article
Open access
PDF file
APAndreea Pricopie
Andreea Pricopie
Ioana IonuțIoana Ionuț
Ioana Ionuț
GMGabriel Marc
Gabriel Marc
ABAnca-Maria Borcea
Anca-Maria Borcea
Laurian VlaseLaurian Vlase
Laurian Vlase
OOOvidiu Oniga
Ovidiu Oniga
In the context of there being a limited number of clinically approved drugs for the treatment of Candida sp.-based infections, along with the rapid development of resistance to the existing antifungals, two novel series of 4-phenyl-1,3-thiazole and 2-hydrazinyl-4-phenyl-1,3-thiazole derivatives were synthesized and tested in vitro for their anti-Candida potential. Two compounds (7a and 7e) showed promising inhibitory activity against the pathogenic C. albicans strain, exhibiting substantially lower MIC values (7.81 μg/mL and 3.9 μg/mL, respectively) as compared with the reference drug fluconazole (15.62 μg/mL). Their anti-Candida activity is also supported by molecular docking studies, using the fungal lanosterol C14α-demethylase as the target enzyme. The interaction of the most biologically active synthesized compound 7e with bovine serum albumin was investigated through fluorescence spectroscopy, and the obtained data suggested that this molecule might efficiently bind carrier proteins in vivo in order to reach the target site.

9 January 2024 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
Daniel UngureanuDaniel Ungureanu
Daniel Ungureanu
Brindusa TiperciucBrindusa Tiperciuc
Brindusa Tiperciuc
CMCristina Moldovan
Cristina Moldovan
Ioana IonuțIoana Ionuț
Ioana Ionuț
GMGabriel Marc
Gabriel Marc
OOOvidiu Oniga
Ovidiu Oniga
Antimicrobial resistance is an increasing problem for global public health. One of the strategies to combat this issue is the synthesis of novel antimicrobials through rational drug design based on extensive structure–activity relationship studies. The thiazole nucleus is a prominent feature in the structure of many authorized antimicrobials, being clubbed with different heterocycles. The purpose of this review is to study the structure–activity relationship in antimicrobial thiazoles clubbed with various heterocycles, as reported in the literature between 2017 and 2023, in order to offer an overview of the last years in terms of antimicrobial research and provide a helpful instrument for future research in the field.

2 October 2018 in Molecules
Verified
Journal Article
Open access
PDF file
GMGabriel Marc
Gabriel Marc
CACătălin Araniciu
Cătălin Araniciu
Smaranda Dafina OnigaSmaranda Dafina Oniga
Smaranda Dafina Oniga
Laurian VlaseLaurian Vlase
Laurian Vlase
APAdrian Pirnau
Adrian Pirnau
OOOvidiu Oniga
Ovidiu Oniga
C. albicans is the most frequently occurring fungal pathogen, and is becoming an increasing public health problem, especially in the context of increased microbial resistance. This opportunistic pathogen is characterized by a versatility explained mainly by its ability to form complex biofilm structures that lead to enhanced virulence and antibiotic resistance. In this context, a review of the known C. albicans biofilm formation inhibitors were performed and a new N-(oxazolylmethyl)-thiazolidinedione scaffold was constructed. 16 new compounds were synthesized and characterized in order to confirm their proposed structures. A general antimicrobial screening against Gram-positive and Gram-negative bacteria, as well as fungi, was performed and revealed that the compounds do not have direct antimicrobial activity. The anti-biofilm activity evaluation confirmed the compounds act as selective inhibitors of C. albicans biofilm formation. In an effort to substantiate this biologic profile, we used in silico investigations which suggest that the compounds could act by binding, and thus obstructing the functions of, the C. albicans Als surface proteins, especially Als1, Als3, Als5 and Als6. Considering the well documented role of Als1 and Als3 in biofilm formation, our new class of compounds that target these proteins could represent a new approach in C. albicans infection prevention and management.